Home NDC 72677-551 UPLIZNA
Product NDC 72677-551
11-digit product format 726770551
Labeler code 72677
Product ID 72677-551_7edce787-91e3-4b7d-9800-66711a5c096f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Inebilizumab
Dosage form INJECTION
Route INTRAVENOUS
Labeler Viela Bio, Inc.
Application BLA761142
Marketing category BLA
Marketing start 2020-06-11
Marketing end 0000-00-00
Substance INEBILIZUMAB
Active strength 10 mg/mL
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join UPLIZNA INEBILIZUMAB Horizon Therapeutics USA, Inc. 834db232-afb0-4dcf-93e0-009ce8245c20 2025-12-11 Warnings, Adverse reactions Exact identifier application number: BLA761142
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72677-551 UPLIZNA (INEBILIZUMAB) INJECTION [VIELA BIO, INC.] 9 Legacy NDC 20221221_0ce5e7f6-eb97-4738-8b10-43b89e16b5b3.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761142 Uplizna inebilizumab-cdon 351(a) Rx 2026-06-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 72677-551-01 72677055101 3 VIAL, SINGLE-DOSE in 1 CARTON (72677-551-01) > 10 mL in 1 VIAL, SINGLE-DOSE (72677-551-03) 2020-06-11 0000-00-00 No No Current